Which element describes how long subjects participate and when follow-up occurs, including subsequent trial periods?

• A. The expected duration of participation and the sequence of trial periods
• B. The sponsor's communication plan
• C. The patient compensation policy
• D. The data monitoring committee charter

Answer: (A)

The plan for how long subjects participate and when follow-up occurs, including any subsequent trial periods, is captured in the participant timeline within the protocol. This describes the expected duration of participation and the sequence of trial periods (screening, treatment, follow-up, extension, etc.), along with the timing of visits and assessments. It guides both consent discussions and day-to-day study conduct, ensuring data collection is consistent, safety monitoring is appropriately timed, and retention is managed.

The other options don’t describe this timing and structure: the sponsor’s communication plan covers how information is shared; the patient compensation policy deals with reimbursement; the data monitoring committee charter outlines safety oversight and interim analyses.